Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin‐Converting Enzyme Inhibitor or Angiotensin‐Receptor Blocker in a Retrospective Analysis of Patients With Heart Failure
2019 ◽
Vol 8
(9)
◽
2009 ◽
Vol 15
(4)
◽
pp. 170-175
◽
2009 ◽
Vol 120
(16)
◽
pp. 1577-1584
◽